| | 1187594-09-7 Basic information More.. |
| Product Name: | Baricitinib | | Synonyms: | 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile;Baricitinib;INCB 028050;LY 3009104;BARICITINIB;INCB28050;LY3009104;Baricitinib (LY3009104);2-(3-(4-(3H-Pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile;Baricitinib/INCB 028050/LY3009104 | | CAS: | 1187594-09-7 | | MF: | C16H17N7O2S | | MW: | 371.42 | | EINECS: | 691-421-4 | | Mol File: | 1187594-09-7.mol |  |
Use
Baricitinib represents a selective inhibitor of JAKs with excellent potency and selectivity for JAK2 (IC50=5.7nM) and JAK1 (IC50=5.9nM), and less potency and selectivity for JAK3 (IC50 >400nM), or TYK2 (IC50=53nM). Although baricitinib potently inhibits JAKs, it does not significantly inhibit (<30% inhibition) a broad panel of 26 other kinases when tested at 200nM.
- Baricitinib
-
- US $43.00-92.00 / mg
- 2024-11-09
- CAS:1187594-09-7
- Min. Order:
- Purity: 99.79%
- Supply Ability: 10g
- Baricitinib
-
- US $80.00-60.00 / KG
- 2024-11-08
- CAS:1187594-09-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 500
- Baricitinib
-
- US $100.00-80.00 / KG
- 2024-11-08
- CAS:1187594-09-7
- Min. Order: 1KG
- Purity: 99.9%
- Supply Ability: 1000
|
|
1187594-09-7
Recommend Suppliers |
|